After weighing both sides, the bull wins the fundamental argument but loses the timing/valuation argument — and that combination points to Overweight rather than Buy. The Q2 2026 print is hard data, not narrative: revenue +22.8% YoY, EPS +51.8% YoY, gross margin +350 bps, and a FCF step-change from $555M to $2.19B YoY driven by a structural capex roll-off (the 300mm fab build is DONE, $1.30B → $0.51B and falling). That capex roll-off is the single most important fact in this debate — it is permanent and largely demand-independent, which means the bear's "what if industrial softens?" risk is partially hedged by a permanently lower capex base. The trend confirms the inflection: all four MAs are bullishly stacked ($293.80 > 10 EMA $278.79 > 50 SMA $270.40 > 200 SMA $247.17), MACD has crossed from deeply negative to positive and is expanding, and the 22-session surge from a 36 RSI low is a fresh-trend ignition, not a melt-up. But the bear wins three important points that prevent a Buy rating. First, the risk/reward math: from $293.80, the bull's $310-313 target is only 5-6% upside, while a 50 SMA stop at $270 is 8% downside — that is roughly 0.7:1, not 3:1. The bull's R/R claim is broken. Second, the breakout is sub-volume (4.93M vs 19.05M on 9/18) and the stock is testing a zone ($310-313) that was REJECTED in July — overhead supply is real. Third, valuation at 27.6x forward is 30-50% above TXN's historical 15-20x band, and the bull's "trailing P/E compresses" argument requires hitting the $10.64 forward EPS to the dollar, which is not a given when Q3 and Q4 comps get brutal ($1.48 and $1.27 bases respectively). The receivables +80% in two quarters vs revenue +23% YoY is a legitimate yellow flag the bull hand-waves away too easily, and the ADI comparison (similar moat, often lower multiple, arguably better industrial positioning) is a real competitive check on the "TXN is the cheapest high-quality analog" claim. The macro is a wash — the bear is right that no-cuts is restrictive not accommodative, and the bull is right that the hawkish tail-risk premium has faded. Neither side wins convincingly there. Synthesis: The fundamental re-rating story is real and supported by Q2 2026 hard data plus a structural capex step-down. The technical trend is decisively bullish. But the entry is not ideal — we are stretched on RSI, sub-volume on the breakout, below the 52-week high, and rich on valuation relative to history. That argues for Overweight, not Buy. We want exposure to the multi-quarter re-rating, but we want to build it with discipline — using any 3-7% pullback toward the 50 SMA/lower Bollinger Band zone ($265-275) to add, rather than chasing the 4.4% rip. A 1-3 day consolidation to retest $280-285 would be healthy, not bearish, and would meaningfully improve the R/R. Positioning: Establish or grow a position, but do not max-size at the current print. The right move is to be long the trend, not to bet the ranch on it.

POSITION STRATEGY: Take an Overweight position in TXN at current levels, but do not deploy full target size on this single print. Initiate roughly 60-70% of intended position now to participate in the trend, with 30-40% reserved for add-on on any pullback to the $278-285 zone (10 EMA / lower Bollinger Band retest).

SCALING DISCIPLINE: If TXN consolidates 3-7 days in the $278-285 range on declining volume, ADD to position toward full Overweight size — that is the highest-probability entry, not chasing the breakout day. If TXN closes below the 50 SMA ($270) on rising volume, PAUSE adds and reassess — that would invalidate the bullish trend structure.

TARGETS: First target $310-313 (prior July swing high — expect resistance here based on the prior rejection). If $310-313 is reclaimed on volume >8M shares, the next leg opens toward $325-334 (52-week high zone). Beyond that, a sustained breakout on heavy volume targets $350+ on a 12-month view if Q3/Q4 2026 deliver on the FCF inflection.

STOPS: Hard stop on a daily close below $260 (below the recent consolidation base and ~12% from current). That preserves the long thesis — a break of the 50 SMA AND the prior base would be a real structural warning, not a tactical wobble. Trailing stop alternative: 50 SMA once the stock pushes above $310.

HEDGING: Given elevated RSI and sub-volume breakout, consider a partial hedge via short-dated puts (1-2 month, $280-285 strike) to protect against mean-reversion while staying long the core position. The bull's R/R at current levels is genuinely uncompelling without some form of downside insurance.

WATCHLIST CATALYSTS: (a) Q3 2026 earnings late October — must show continued FCF strength and gross margin ≥60% to confirm the re-rating; a beat on a $1.48 base is required. (b) Distributor reads (Arrow, Avnet) for any signs of channel restock completing and end-demand normalizing. (c) Fed/10Y yield path — easing yields support multiple expansion, a fresh hawkish surprise compresses it. (d) Any escalation in China export controls — flag immediately for reassessment.

AVOID: Chasing a 5%+ extension on low volume into the $310-313 zone. The bear is right that overhead supply is real. Take profits or hedge into that level rather than pressing fresh longs there.

The investment plan supports an Overweight (Buy) thesis anchored in three pillars: (1) a structural capex roll-off (300mm fab build complete, $1.30B → $0.51B and falling) that drives a permanent FCF step-change from $555M to $2.19B YoY; (2) Q2 2026 hard data confirming the inflection (revenue +22.8% YoY, EPS +51.8% YoY, gross margin +350 bps); and (3) a decisively bullish technical setup with all four MAs bullishly stacked ($293.80 > 10 EMA $278.79 > 50 SMA $270.40 > 200 SMA $247.17), positive and expanding MACD, and an RSI recovery from 36. The Overweight (vs. full Buy) rating is justified by an unfavorable near-term R/R (5-6% upside to $310-313 vs. 8% downside to the 50 SMA), sub-volume breakout (4.93M vs. 19.05M), a prior July rejection at $310-313 creating overhead supply, and forward P/E of 27.6x sitting 30-50% above the historical 15-20x band. Translation: we want exposure to the multi-quarter re-rating, but we build it with discipline — establishing roughly 60-70% of intended size now and reserving 30-40% for a healthy pullback to the $278-285 zone (10 EMA / lower Bollinger Band retest).

Stop loss: $260.00

Sizing: Initiate 60-70% of target Overweight size at current levels ($293.80); reserve 30-40% for add-on on any 3-7% pullback into the $278-285 zone (10 EMA / lower Bollinger Band retest). Do not max-size on this single print.